FindTrial
Sign In

Study of Symptoms and Supportive/Comfort Care for Cancer-Related Wounds in Advanced Cancer Patients

Symptom Burden and Holistic Palliative Interventions for Malignant Wounds in Advanced Cancer: A Retrospective Study from a Tertiary Cancer Centre. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108885
Enrollment
400
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinico-radiological diagnosis of advanced cancer 2. Malignant wound presentation in advanced cancer patients newly referred for SPC 3. Complete documentation of symptom profile and severity in medical records

Exclusion criteria

Exclusion criteria: 1. Incomplete record forms

Design outcomes

Primary

MeasureTime frame
To determine frequency of malignant wounds in advanced cancer patients referred for SPC to Palliative Medicine outpatient department (OPD).Timepoint: Baseline—

Secondary

MeasureTime frame
To assess the symptom profile and its severity at the time of referral.Timepoint: Baseline;To explore the goals of care in this patient group.Timepoint: Baseline;To document wound-related characteristics, including site, presence of bleeding, discharge, odor, and infection.Timepoint: Baseline;To identify sociodemographic, clinical, and treatment modalities includes on intravenous chemotherapy, oral metronomic chemotherapy (OMCT), radiotherapy, best supportive care in advanced cancer patients with malignant wounds referred for SPCTimepoint: Baseline;To document the interventions provided for symptom management and supportive care.Timepoint: Baseline;To assess wound-related symptoms and signs at baseline and at 3-month follow-up.Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Jayita Deodhar

Tata Memorial Centre

jukd2000@yahoo.co.uk9892358023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026